News & Events

May 11, 2022

BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30...

May 9, 2022

BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales

Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of Experience BURLINGTON,...

May 4, 2022

BrainsWay to Present Expanded Post-Marketing Clinical Research for Major Depressive Disorder at Clinical TMS Society

Additional presentations will highlight the utility of Deep TMS™ in Smoking Addiction and OCD BURLINGTON,...

May 21 - May 25, 2022

American Psychiatric Association (APA) Annual Meeting

BrainsWay is attending the American Psychiatric Association Annual Meeting from May 21 through to May...

June 3 - June 4, 2022

European Brain Stimulation

BrainsWay is attending the 5th European Conference of Brain Stimulation in Psychiatry from June 3 through...

June 3 - June 5, 2022

Psych Congress Elevate

BrainsWay is attending Psych Congress Elevate from June 3 through to June 5, 2022, in Las Vegas, Nevada. We...

In the Media

May 17, 2022

Sun Valley throws open its mental health doors

Live the Sun Valley Experience Mental Health Fair held by Sun Valley Medical Center and Sun Valley Research...

March 25, 2022

Breakthrough Treatments for OCD

Detailing Deep TMS as a notable and effective approach for individuals living with medication-resistant...

January 18, 2022

Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD

8-minute video interview with BrainsWay President and CEO, Christopher von Jako providing expertise around...